Bill Text: TX SB2212 | 2023-2024 | 88th Legislature | Engrossed
Bill Title: Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Engrossed - Dead) 2023-05-06 - Referred to Public Health [SB2212 Detail]
Download: Texas-2023-SB2212-Engrossed.html
By: Blanco | S.B. No. 2212 |
|
||
|
||
relating to the disclosure by a pharmacy to a patient of certain | ||
price information for a drug or biological product. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Section 562.003, Occupations Code, is amended to | ||
read as follows: | ||
Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A | ||
pharmacy shall disclose the lowest cost cash price at that pharmacy | ||
for the drug or biological product prescribed to the patient. | ||
(b) If the price of a drug or biological product to a patient | ||
is lower than the amount of the patient's copayment under the | ||
patient's prescription drug insurance plan, the pharmacist shall | ||
offer the patient the option of paying for the drug or biological | ||
product at the lower price instead of paying the amount of the | ||
copayment. | ||
SECTION 2. This Act takes effect September 1, 2023. |